Compare OGEN & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGEN | XPON |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.6M |
| IPO Year | 2010 | 2022 |
| Metric | OGEN | XPON |
|---|---|---|
| Price | $0.16 | $2.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 246.6K | 11.4K |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.63 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,651,870.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 71.59 |
| 52 Week Low | $0.13 | $0.26 |
| 52 Week High | $1.11 | $11.79 |
| Indicator | OGEN | XPON |
|---|---|---|
| Relative Strength Index (RSI) | 14.14 | 25.93 |
| Support Level | N/A | $0.48 |
| Resistance Level | $0.59 | $3.82 |
| Average True Range (ATR) | 0.03 | 0.32 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 10.60 | 0.00 |
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Expion Energy Inc is engaged in premium lithium iron phosphate (LiFePO4) batteries and accessories for recreational vehicles, marine applications, Light EV and industrial applications. The company's lithium-ion batteries feature half the weight of standard lead-acid batteries while delivering three times the power and ten times the number of charging cycles. The company's batteries also feature construction and reliability compared to other lithium-ion batteries on the market due to their superior design and quality materials.